Locations:
Search IconSearch

Rheumatology & Immunology

covid-19
December 28, 2020/COVID-19

Studies Suggest Interferon as Tool to Manage COVID-19

Treatments could help patients suffer less, recover faster

20-RHE-2006260-Langford_VEXAS-syndrome-CQD-650×450

Relapsing Polychondritis or Something More?

The identification of a novel disorder: the VEXAS syndrome

20-RHE-2001145-Littlejohn_LongitudinalVariationANA-titers-RC2020-CQD-1-650×450 (3)

Longitudinal Variation in ANA Titers

ANA titers may by more dynamic than previously accepted

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-RHE-2006261-Deal_Keller_Erdheim-ChesterDisease-CQD-650×450

Paget Disease in a 36-Year-Old Patient?

Puzzling constellation of findings lead to CT-guided bone biopsy

20-RHE-1956541-DermRheumClinic-HusniFernandez-CQD-650×450

Collaborative Rheumatology-Dermatology Clinic Improves Outcomes

Co-management increases opportunities for research and education

covid-19-SARS-CoV-2-Virus-v1_650x450
November 4, 2020/COVID-19

IL-6 Targeting in COVID-19 Treatment

Safety and efficacy remain in question

20-RHE-1996207-Ungprasert_Systemic-LupusErythematosus-Asthma-CQD-650×450
November 3, 2020/Pulmonary

Assessing the Relationship Between Systemic Lupus Erythematosus and Asthma

Study finds patients with asthma are at higher risk for developing SLE

SARS-CoV-2 virus microville
October 21, 2020/COVID-19

Cytokine Storm and the Prospects for Immunotherapy With COVID-19

Anti-IL-6 and anti-IL-1 agents: Center stage for COVID-19 stage 3 disease

BackPage 10 of 30Next

Advertisement

Ad